FDA Application
-
NDC Search Results on Active Ingredient: acetaminophen
Click on Active Ingredient to view the label.
Ingredient Name | NDC | Company Name | Application Number or Regulatory Citation | Product Type | Marketing Category |
---|---|---|---|---|---|
OXYCODONE HYDROCHLORIDE; ACETAMINOPHEN | 42858-102-10 | Rhodes Pharmaceuticals L.P. | ANDA201278 | HUMAN PRESCRIPTION DRUG | ANDA |
OXYCODONE HYDROCHLORIDE; ACETAMINOPHEN | 42858-102-50 | Rhodes Pharmaceuticals L.P. | ANDA201278 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE | 42858-103-01 | Rhodes Pharmaceuticals L.P. | ANDA201278 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE | 42858-103-10 | Rhodes Pharmaceuticals L.P. | ANDA201278 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE | 42858-103-50 | Rhodes Pharmaceuticals L.P. | ANDA201278 | HUMAN PRESCRIPTION DRUG | ANDA |
OXYCODONE HYDROCHLORIDE; ACETAMINOPHEN | 42858-104-01 | Rhodes Pharmaceuticals L.P. | ANDA201278 | HUMAN PRESCRIPTION DRUG | ANDA |
OXYCODONE HYDROCHLORIDE; ACETAMINOPHEN | 42858-104-10 | Rhodes Pharmaceuticals L.P. | ANDA201278 | HUMAN PRESCRIPTION DRUG | ANDA |
OXYCODONE HYDROCHLORIDE; ACETAMINOPHEN | 42858-104-50 | Rhodes Pharmaceuticals L.P. | ANDA201278 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; HYDROCODONE BITARTRATE | 42858-201-01 | Rhodes Pharmaceuticals L.P. | ANDA202991 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; HYDROCODONE BITARTRATE | 42858-201-10 | Rhodes Pharmaceuticals L.P. | ANDA202991 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; HYDROCODONE BITARTRATE | 42858-201-50 | Rhodes Pharmaceuticals L.P. | ANDA202991 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; HYDROCODONE BITARTRATE | 42858-202-01 | Rhodes Pharmaceuticals L.P. | ANDA202991 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; HYDROCODONE BITARTRATE | 42858-202-10 | Rhodes Pharmaceuticals L.P. | ANDA202991 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; HYDROCODONE BITARTRATE | 42858-203-01 | Rhodes Pharmaceuticals L.P. | ANDA202991 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; HYDROCODONE BITARTRATE | 42858-203-10 | Rhodes Pharmaceuticals L.P. | ANDA202991 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; HYDROCODONE BITARTRATE | 42858-203-50 | Rhodes Pharmaceuticals L.P. | ANDA202991 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; HYDROCODONE BITARTRATE | 42858-203-90 | Rhodes Pharmaceuticals L.P. | ANDA202991 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN | 42912-0152-7 | TDS Pharm., Co., Ltd. | part343 | HUMAN OTC DRUG | OTC monograph not final |
ACETAMINOPHEN | 42912-0153-6 | TDS Pharm., Co., Ltd. | part343 | HUMAN OTC DRUG | OTC monograph not final |
DIPHENHYDRAMINE HYDROCHLORIDE; ACETAMINOPHEN | 42912-0154-2 | TDS Pharm., Co., Ltd. | part343 | HUMAN OTC DRUG | OTC monograph not final |
ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE | 42961-112-10 | Cintas Corporation | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE | 42961-112-11 | Cintas Corporation | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE | 42961-112-12 | Cintas Corporation | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
PHENYLEPHRINE HYDROCHLORIDE; ACETAMINOPHEN | 42961-126-01 | Cintas Corporation | part341 | HUMAN OTC DRUG | OTC monograph final |
PHENYLEPHRINE HYDROCHLORIDE; ACETAMINOPHEN | 42961-126-02 | Cintas Corporation | part341 | HUMAN OTC DRUG | OTC monograph final |
CAFFEINE; ACETAMINOPHEN; ASPIRIN | 42961-202-01 | Cintas Corporation | ANDA075794 | HUMAN OTC DRUG | ANDA |
CAFFEINE; ACETAMINOPHEN; ASPIRIN | 42961-202-02 | Cintas Corporation | ANDA075794 | HUMAN OTC DRUG | ANDA |
ACETAMINOPHEN; CAFFEINE; ASPIRIN | 42961-234-01 | Cintas Corporation | part343 | HUMAN OTC DRUG | OTC monograph not final |
ACETAMINOPHEN; CAFFEINE; ASPIRIN | 42961-234-02 | Cintas Corporation | part343 | HUMAN OTC DRUG | OTC monograph not final |
ACETAMINOPHEN; CAFFEINE; ASPIRIN | 42961-234-03 | Cintas Corporation | part343 | HUMAN OTC DRUG | OTC monograph not final |
-